Literature DB >> 2874366

Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study.

D A Sykes, R Wilson, K L Chan, I S Mackay, P J Cole.   

Abstract

50 patients with chronic mucopurulent rhinosinusitis were randomly allocated to treatment with nasal sprays of dexamethasone, tramazoline, and neomycin, dexamethasone and tramazoline with no antibiotic, or matched placebo (propellant alone) four times daily to both nostrils for 2 weeks. The patients were assessed in a double-blind manner for symptomatic response and improvement in nasal mucociliary clearance, nasal airway resistance, sinus radiographs, and intranasal bacteriology and appearance. Both active preparations (with antibiotic 14 of 20 patients responded; without antibiotic 12 of 20 patients responded) were more effective than the placebo (2 of 10 patients responded). There was no significant difference in response between the active preparations with and without antibiotic. Thus, in treatment of chronic mucopurulent rhinosinusitis, reduction of the inflammatory response and decongestion make topical antibiotic unnecessary, probably by allowing host clearance mechanisms to recover.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874366     DOI: 10.1016/s0140-6736(86)90051-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

1.  Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Authors:  Umur Hatipo; Israel Rubinstein
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

Review 2.  Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines.

Authors:  Eli O Meltzer; Daniel L Hamilos
Journal:  Mayo Clin Proc       Date:  2011-04-13       Impact factor: 7.616

Review 3.  Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: systematic review and meta-analysis.

Authors:  Kornkiat Snidvongs; Larry Kalish; Raymond Sacks; Rahuram Sivasubramaniam; Daron Cope; Richard J Harvey
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

Review 4.  Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Authors:  Umur Hatipoğlu; Israel Rubinstein
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

5.  [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; K Hörmann
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

6.  [Significance of Haemophilus influenzae and other microorganisms for the pathogenesis and therapy of chronic respiratory infection].

Authors:  P J Cole
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 7.  Chronic obstructive pulmonary disease and asthma. General and medical management with special attention to exacerbations.

Authors:  J P Kaajan
Journal:  Pharm Weekbl Sci       Date:  1989-08-25

Review 8.  Update on Intranasal Medications in Rhinosinusitis.

Authors:  Kornkiat Snidvongs; Sanguansak Thanaviratananich
Journal:  Curr Allergy Asthma Rep       Date:  2017-07       Impact factor: 4.806

9.  Acute sinusitis: guide to selection of antibacterial therapy.

Authors:  Morten Lindbaek
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Sinusitis. A review for generalists.

Authors:  J B Reuler; L M Lucas; K L Kumar
Journal:  West J Med       Date:  1995-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.